Involvement of nitric oxide in the inhibition of bone cancer-induced hyperalgesia through the activation of peripheral opioid receptors in mice

Neuropharmacology

Volumn 53, Issue 1, 2007, Pages 71-80

  Menéndez, Luis ^a   Juárez, Lucía ^a   García, Verónica ^b   Hidalgo, Agustín ^a   Baamonde, Ana ^a  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^b Centro Comunitario de Sangre y Tejidos del Principado de Asturias   (Spain)

Author keywords

Bone cancer induced hyperalgesia; Inflammation; Loperamide; Mouse; Nitric oxide (NO); Osteosarcoma; Peripheral opiates

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ARGININE DERIVATIVE; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLIBENCLAMIDE; GUANYLATE CYCLASE INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; KT 5823; LOPERAMIDE; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; N OMEGA PROPYLARGININE; N(G) METHYLARGININE; N5 (1 IMINOETHYL)ORNITHINE; NALOXONE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC ACID DERIVATIVE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; OPIATE ANTAGONIST; OPIATE RECEPTOR; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C3H MOUSE; CHRONIC INFLAMMATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG MECHANISM; HOT PLATE TEST; HYPERALGESIA; MOUSE; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; TUMOR MODEL;

ANALYSIS OF VARIANCE; ANIMALS; BONE NEOPLASMS; CARBAZOLES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; DRUG INTERACTIONS; ENZYME ACTIVATION; ENZYME INHIBITORS; GLYBURIDE; HYPERALGESIA; INDOLES; LOPERAMIDE; MICE; MICE, INBRED C3H; NALOXONE; NARCOTIC ANTAGONISTS; NG-NITROARGININE METHYL ESTER; NITRATES; NITRIC OXIDE; NITRITES; PAIN MEASUREMENT; RECEPTORS, OPIOID;

EID: 34547232749     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2007.04.011     Document Type: Article

References (44)

1. Abacioglu N., Ozmen R., Cakici I., Tunctan B., and Kanzik I. Role of L-arginine/nitric oxide pathway in the antinociceptive activities of morphine and mepyramine in mice. Arzneimittelforschung 51 (2001) 977-983
2. Alves D.P., Soares A.C., Francischi J.N., Castro M.S., Perez A.C., and Duarte I.D. Additive antinociceptive effect of the combination of diazoxide, an activator of ATP-sensitive K+ channels, and sodium nitroprusside and dibutyryl-cGMP. European Journal of Pharmacology 489 (2004) 59-65
3. Baamonde A., Lastra A., Juarez L., Garcia V., Hidalgo A., and Menendez L. Effects of the local administration of selective mu-, delta-and kappa-opioid receptor agonists on osteosarcoma-induced hyperalgesia. Naunyn Schmiedebergs Archives of Pharmacology 372 (2005) 213-219
4. Baamonde A., Lastra A., Juarez L., Garcia-Suarez O., Meana A., Hidalgo A., and Menendez L. Endogenous beta-endorphin induces thermal analgesia at the initial stages of a murine osteosarcoma. Peptides 27 (2006) 2778-2785
5. Beirith A., Santos A.R., and Calixto J.B. Mechanisms underlying the nociception and paw oedema caused by injection of glutamate into the mouse paw. Brain Research 924 (2002) 219-228
6. Bohn L.M., and Raehal K.M. Opioid receptor signaling: relevance for gastrointestinal therapy. Current Opinion in Pharmacology 6 (2006) 559-563
7. Cadet P. Mu opiate receptor subtypes. Medical Science Monitor 10 (2004) MS28-MS32
8. Endres-Becker J., Heppenstall P.A., Mousa S.A., Labuz D., Oksche A., Schäfer M., Stein C., and Zöllner C. μ-Opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain. Molecular Pharmacology 71 (2007) 12-18
9. Escribano M., Molero L., Lopez-Farre A., Abarrategui C., Carrasco C., Garcia-Mendez A., Manzarbeitia F., Martin M.J., Vazquez M., Sanchez-Fayos P., Rico L., and Porres Cubero J.C. Aspirin inhibits endothelial nitric oxide synthase (eNOS) and Flk-1 (vascular endothelial growth factor receptor-2) prior to rat colon tumour development. Clinical Sciences (Lond.) 106 (2004) 83-91
10. Ferreira S.H. Peripheral analgesia: mechanism of the analgesic action of aspirin-like drugs and opiate-antagonists. British Journal of Clinical Pharmacology 10 Suppl. 2 (1980) 237S-245S
11. Ferreira S.H., Duarte I.D., and Lorenzetti B.B. The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release. European Journal of Pharmacology 201 (1991) 121-122
12. Foss J.F. A review of the potential role of methylnaltrexone in opioid bowel dysfunction. American Journal of Surgery 182 5A Suppl. (2001) 19S-26S
13. Gaitan G., Ahuir F.J., Del Soldado P., and Herrero J.F. Comparison of the antinociceptive activity of two new NO-releasing derivatives of the NSAID S-ketoprofen in rats. British Journal of Pharmacology 143 (2004) 533-540
14. Garvey E.P., Oplinger J.A., Furfine E.S., Kiff R.J., Laszlo F., Whittle B.J., and Knowles R.G. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. Journal of Biological Chemistry 272 (1997) 4959-4963
15. Granados-Soto V., Flores-Murrieta F.J., Castaneda-Hernandez G., and Lopez-Munoz F.J. Evidence for the involvement of nitric oxide in the antinociceptive effect of ketorolac. European Journal of Pharmacology 277 (1995) 281-284
16. Granados-Soto V., Rufino M.O., Gomes Lopes L.D., and Ferreira S.H. Evidence for the involvement of the nitric oxide-cGMP pathway in the antinociception of morphine in the formalin test. European Journal of Pharmacology 340 (1997) 177-180
17. Gupta K., Kshirsagar S., Chang L., Schwartz R., Law P.Y., Yee D., and Hebbel R.P. Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Research 62 (2002) 4491-4498
18. Ishide T., Presuss C.V., Maher T.J., and Ally A. Neurochemistry within ventrolateral medulla and cardiovascular effects during static exercise following eNOS antagonism. Neuroscience Research 52 (2005) 21-30
19. Kolesnikov Y., and Pasternak G.W. Topical opioids in mice: analgesia and reversal of tolerance by a topical n-methyl-d-aspartate antagonist. Journal of Pharmacology and Experimental Therapeutics 290 (1999) 247-252
20. Kolesnikov Y., Jain S., Wilson R., and Pasternak G.W. Peripheral kappa 1-opioid receptor-mediated analgesia in mice. European Journal of Pharmacology 310 (1996) 141-143
21. Lauretti G.R., Lima I.C., Reis M.P., Prado W.A., and Pereira N.L. Oral ketamine and transdermal nitroglycerin as analgesic adjuvants to oral morphine therapy for cancer pain management. Anesthesiology 90 (1999) 1528-1533
22. Lauretti G.R., Oliveira A.P., Rodrigues A.M., and Paccola C.A. The effect of transdermal nitroglycerin on spinal S(+)-ketamine antinociception following orthopedic surgery. Journal of Clinical Anesthesia 13 (2001) 576-581
23. Lauretti G.R., Perez M.V., Reis M.P., and Pereira N.L. Double-blind evaluation of transdermal nitroglycerine as adjuvant to oral morphine for cancer pain management. Journal of Clinical Anesthesia 14 (2002) 83-86
24. Lorenzetti B.B., and Ferreira S.H. Activation of the arginine-nitric oxide pathway in primary sensory neurons contributes to dipyrone-induced spinal and peripheral analgesia. Inflammation Research 45 (1996) 308-311
25. Maegawa F.A., and Tonussi C.R. The L-arginine/nitric oxide/cyclic-GMP pathway apparently mediates the peripheral antihyperalgesic action of fentanyl in rats. Brazilian Journal of Medical and Biological Research 36 (2003) 1701-1707
26. Medhurst S.J., Walker K., Bowes M., Kidd B.L., Glatt M., Muller M., Hattenberger M., Vaxelaire J., O'Reilly T., Wotherspoon G., Winter J., Green J., and Urban L. A rat model of bone cancer pain. Pain 96 (2002) 129-140
27. Menéndez L., Lastra A., Hidalgo A., and Baamonde A. Unilateral hot plate: a simple and sensitive method for detecting central and peripheral hyperalgesia in mice. Journal of Neuroscience Methods 113 (2002) 91-97
28. Menéndez L., Lastra A., Fresno M.F., Llames S., Meana A., Hidalgo A., and Baamonde A. Initial thermal heat hypoalgesia and delayed hyperalgesia in a murine model of bone cancer pain. Brain Research 969 (2003) 102-109
29. Menéndez L., Lastra A., Hidalgo A., Meana A., Garcia E., and Baamonde A. Peripheral opioids act as analgesics in bone cancer pain in mice. Neuroreport 14 (2003) 867-869
30. Menéndez L., Lastra A., Meana A., Hidalgo A., and Baamonde A. Analgesic effects of loperamide in bone cancer pain in mice. Pharmacology Biochemistry and Behavior 81 (2005) 114-121
31. Moshage H., Kok B., Huizenga J.R., and Jansen P.L. Nitrite and nitrate determinations in plasma: a critical evaluation. Clinical Chemistry 41 (1995) 892-896
32. Obara I., Przewlocki R., and Przewlocka B. Local peripheral effects of mu-opioid receptor agonists in neuropathic pain in rats. Neuroscience Letters 360 (2004) 85-89
33. Rees D.D., Palmer R.M., Schulz R., Hodson H.F., and Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. British Journal of Pharmacology 101 (1990) 746-752
34. Rodrigues A.R., and Duarte I.D. The peripheral antinociceptive effect induced by morphine is associated with ATP-sensitive K(+) channels. British Journal of Pharmacology 129 (2000) 110-114
35. Sachs D., Cunha F.Q., and Ferreira S.H. Peripheral analgesic blockade of hypernociception: activation of arginine/NO/cGMP/protein kinase G/ATP-sensitive K+ channel pathway. Proceedings of the National Academy of Sciences USA 101 (2004) 3680-3685
36. Schnitzer T.J., Kivitz A.J., Lipetz R.S., Sanders N., and Hee A. Comparison of the COX-inhibiting nitric oxide donator AZD3582 and rofecoxib in treating the signs and symptoms of osteoarthritis of the knee. Arthritis & Rheumatism 53 (2005) 827-837
37. Schwei M.J., Honore P., Rogers S.D., Salak-Johnson J.L., Finke M.P., Ramnaraine M.L., Clohisy D.R., and Mantyh P.W. Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. Journal of Neurosciences 19 (1999) 10886-10897
38. Sen S., Ugur B., Aydin O.N., Ogurlu M., Gursoy F., and Savk O. The analgesic effect of nitroglycerin added to lidocaine on intravenous regional anesthesia. Anesthesia and Analgesia 102 (2006) 916-920
39. Shinoda K., Hruby V.J., and Porreca F. Antihyperalgesic effects of loperamide in a model of rat neuropathic pain are mediated by peripheral delta-opioid receptors. Neuroscience Letters 411 (2007) 143-146
40. Stein C., Schafer M., and Machelska H. Attacking pain at its source: new perspectives on opioids. Nature Medicine 9 (2003) 1003-1008
41. Tonussi C.R., and Ferreira S.H. Mechanism of diclofenac analgesia: direct blockade of inflammatory sensitization. European Journal of Pharmacology 251 (1994) 173-179
42. Yagihashi N., Kasajima H., Sugai S., Matsumoto K., Ebina Y., Morita T., Murakami T., and Yagihashi S. Increased in situ expression of nitric oxide synthase in human colorectal cancer. Virchows Archiv 436 (2000) 109-114
43. Zhang H.Q., Fast W., Marletta M.A., Martasek P., and Silverman R.B. Potent and selective inhibition of neuronal nitric oxide synthase by Nomega-propyl-l-arginine. Journal of Medicinal Chemistry 40 (1997) 3869-3870
44. Zhang R.X., Liu B., Wang L., Ren K., Qiao J.T., Berman B.M., and Lao L. Spinal glial activation in a new rat model of bone cancer pain produced by prostate cancer cell inoculation of the tibia. Pain 118 (2005) 125-136